The international study of pregnancy outcome in women with maternal phenylketonuria: Report of a 12-year study

Lawrence D. Platt; Richard Koch; William B. Hanley; Harvey L. Levy; Reuben Matalon; Bobbye Rouse; Fritz Trefz; Felix De la Cruz; Flemming Güttler; Colleen Azen; Eva Gross Friedman

doi:10.1016/S0002-9378(00)70219-5

The international study of pregnancy outcome in women with maternal phenylketonuria: Report of a 12-year study

Lawrence D. Platt, Richard Koch, William B. Hanley, Harvey L. Levy, Reuben Matalon, Bobbye Rouse, Fritz Trefz, Felix De la Cruz, Flemming Güttler, Colleen Azen, Eva Gross Friedman

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Abstract

OBJECTIVE: The purpose of this report was to update the results of the Maternal Phenylketonuria Collaborative Study, which was established to assess the efficacy of a phenylalanine-restricted diet in preventing morbidity among the offspring of women with hyperphenylalaninemia. STUDY DESIGN: During a 12- year period 576 women with hyperphenylalaninemia were enrolled in this study. Outcome measures were stratified according to classification of maternal hyperphenylalaninemia and the time at which dietary control of phenylalanine level was achieved. RESULTS: Optimal physical and cognitive fetal outcomes occurred when maternal blood phenylalanine level <600 μmol/L was achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester average, ≤600 μmol/L). CONCLUSIONS: The achievement of blood phenylalanine level control through a phenylalanine-restricted diet significantly diminished the occurrence of congenital abnormalities among offspring of women with hyperphenylalaninemia and improved early intellectual progress of these offspring. (Am J Obstet Gynecol 2000;182:326-33.).

Original language	English (US)
Pages (from-to)	326-333
Number of pages	8
Journal	American journal of obstetrics and gynecology
Volume	182
Issue number	2
DOIs	https://doi.org/10.1016/S0002-9378(00)70219-5
State	Published - 2000
Externally published	Yes

Keywords

Congenital defects
Fetal development
Maternal phenylketonuria
Mental retardation

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/S0002-9378(00)70219-5

Cite this

Platt, L. D., Koch, R., Hanley, W. B., Levy, H. L., Matalon, R., Rouse, B., Trefz, F., De la Cruz, F., Güttler, F., Azen, C., & Friedman, E. G. (2000). The international study of pregnancy outcome in women with maternal phenylketonuria: Report of a 12-year study. American journal of obstetrics and gynecology, 182(2), 326-333. https://doi.org/10.1016/S0002-9378(00)70219-5

@article{370a67f17a26460db44034cf93d22f59,

title = "The international study of pregnancy outcome in women with maternal phenylketonuria: Report of a 12-year study",

abstract = "OBJECTIVE: The purpose of this report was to update the results of the Maternal Phenylketonuria Collaborative Study, which was established to assess the efficacy of a phenylalanine-restricted diet in preventing morbidity among the offspring of women with hyperphenylalaninemia. STUDY DESIGN: During a 12- year period 576 women with hyperphenylalaninemia were enrolled in this study. Outcome measures were stratified according to classification of maternal hyperphenylalaninemia and the time at which dietary control of phenylalanine level was achieved. RESULTS: Optimal physical and cognitive fetal outcomes occurred when maternal blood phenylalanine level <600 μmol/L was achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester average, ≤600 μmol/L). CONCLUSIONS: The achievement of blood phenylalanine level control through a phenylalanine-restricted diet significantly diminished the occurrence of congenital abnormalities among offspring of women with hyperphenylalaninemia and improved early intellectual progress of these offspring. (Am J Obstet Gynecol 2000;182:326-33.).",

keywords = "Congenital defects, Fetal development, Maternal phenylketonuria, Mental retardation",

author = "Platt, {Lawrence D.} and Richard Koch and Hanley, {William B.} and Levy, {Harvey L.} and Reuben Matalon and Bobbye Rouse and Fritz Trefz and {De la Cruz}, Felix and Flemming G{\"u}ttler and Colleen Azen and Friedman, {Eva Gross}",

year = "2000",

doi = "10.1016/S0002-9378(00)70219-5",

language = "English (US)",

volume = "182",

pages = "326--333",

journal = "American journal of obstetrics and gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "2",

}

TY - JOUR

T1 - The international study of pregnancy outcome in women with maternal phenylketonuria

T2 - Report of a 12-year study

AU - Platt, Lawrence D.

AU - Koch, Richard

AU - Hanley, William B.

AU - Levy, Harvey L.

AU - Matalon, Reuben

AU - Rouse, Bobbye

AU - Trefz, Fritz

AU - De la Cruz, Felix

AU - Güttler, Flemming

AU - Azen, Colleen

AU - Friedman, Eva Gross

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: The purpose of this report was to update the results of the Maternal Phenylketonuria Collaborative Study, which was established to assess the efficacy of a phenylalanine-restricted diet in preventing morbidity among the offspring of women with hyperphenylalaninemia. STUDY DESIGN: During a 12- year period 576 women with hyperphenylalaninemia were enrolled in this study. Outcome measures were stratified according to classification of maternal hyperphenylalaninemia and the time at which dietary control of phenylalanine level was achieved. RESULTS: Optimal physical and cognitive fetal outcomes occurred when maternal blood phenylalanine level <600 μmol/L was achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester average, ≤600 μmol/L). CONCLUSIONS: The achievement of blood phenylalanine level control through a phenylalanine-restricted diet significantly diminished the occurrence of congenital abnormalities among offspring of women with hyperphenylalaninemia and improved early intellectual progress of these offspring. (Am J Obstet Gynecol 2000;182:326-33.).

AB - OBJECTIVE: The purpose of this report was to update the results of the Maternal Phenylketonuria Collaborative Study, which was established to assess the efficacy of a phenylalanine-restricted diet in preventing morbidity among the offspring of women with hyperphenylalaninemia. STUDY DESIGN: During a 12- year period 576 women with hyperphenylalaninemia were enrolled in this study. Outcome measures were stratified according to classification of maternal hyperphenylalaninemia and the time at which dietary control of phenylalanine level was achieved. RESULTS: Optimal physical and cognitive fetal outcomes occurred when maternal blood phenylalanine level <600 μmol/L was achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester average, ≤600 μmol/L). CONCLUSIONS: The achievement of blood phenylalanine level control through a phenylalanine-restricted diet significantly diminished the occurrence of congenital abnormalities among offspring of women with hyperphenylalaninemia and improved early intellectual progress of these offspring. (Am J Obstet Gynecol 2000;182:326-33.).

KW - Congenital defects

KW - Fetal development

KW - Maternal phenylketonuria

KW - Mental retardation

UR - http://www.scopus.com/inward/record.url?scp=0033997846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033997846&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(00)70219-5

DO - 10.1016/S0002-9378(00)70219-5

M3 - Article

C2 - 10694332

AN - SCOPUS:0033997846

SN - 0002-9378

VL - 182

SP - 326

EP - 333

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

IS - 2

ER -

The international study of pregnancy outcome in women with maternal phenylketonuria: Report of a 12-year study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this